XOMAP Q2 2023 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+68.7% YoY

Gross Profit

$2M97.6% margin

Operating Income

-$6M-359.3% margin

Net Income

-$5M-325.7% margin

EPS (Diluted)

$-0.47

QoQ Revenue Growth

+279.4%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$126M

Total Liabilities

$16M

Stockholders' Equity

$110M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$983,000	+68.7%
Gross Profit	$2M	$943,000	+71.7%
Operating Income	-$6M	-$5M	-25.0%
Net Income	-$5M	-$5M	-15.6%